Pharmacovigilance and communicating safety information.

  • Published 2012 in Drug and therapeutics bulletin

Abstract

Safe and effective prescribing can only happen when the prescriber has sufficient current knowledge of the potential harms and likely benefits of the drug. When a new drug is first marketed, knowledge about its adverse effects profile is limited to what has been learned from its use in a relatively small number of people (who may be unrepresentative of the… (More)
DOI: 10.1136/dtb.2012.11.0147

Topics

  • Presentations referencing similar topics